Skip to main content
. 2022 Mar 21;12:861151. doi: 10.3389/fonc.2022.861151

Table 2.

VI in different molecular subgroups of breast cancer.

Subgroup Number (%) VI (%)
M (25%~75%) Range
Luminal A 41 (18.2) 5.9 (2.6~11.6) 0~47.1
Luminal B HER-2-negative 91 (40.4) 7.3 (4.4~10.5) 0~29.5
Luminal B HER-2-positive 26 (11.6) 6.3 (3.9~11.3) 0.6~22.2
HER-2-positive 17 (7.6) 8.2 (4.9~15.6) 0.9~54.4
Triple-negative 50 (22.2) 9.2 (5.1~15.3) 0.7~32.9
Total 225 (100) 7.3 (4.2~11.8) 0~54.4

Single-factor analysis of variance and Bonferroni correction showed no significant differences among the five subgroups (F = 1.855; P = 0.119) and any two subgroups (P > 0.05).

VI (%)M (25%~75%), Vascular index (%) Median (25%~75%); ER, estrogen receptor; HER-2, human epidermal growth factor receptor-2.